{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T17:10:36Z","timestamp":1648919436982},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T00:00:00Z","timestamp":1377907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00103-013-1801-7","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T10:42:08Z","timestamp":1377772928000},"page":"1260-1269","source":"Crossref","is-referenced-by-count":4,"title":["Effektivit\u00e4t, Populationseffekte und Gesundheits\u00f6konomie der Impfungen gegen Masern und R\u00f6teln"],"prefix":"10.1007","volume":"56","author":[{"given":"O.","family":"Wichmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ultsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,31]]},"reference":[{"key":"1801_CR1","unstructured":"Plotkin S, Orenstein W, Offit P (2012) Vaccines. Elsevier, Philadelphia"},{"key":"1801_CR2","doi-asserted-by":"crossref","first-page":"D91","DOI":"10.1016\/j.vaccine.2011.04.059","volume":"29","author":"Andrus","year":"2011","unstructured":"Andrus JK, Quadros CA de, Solorzano CC et al (2011) Measles and rubella eradication in the Americas. Vaccine 29(Suppl 4):D91\u2013D96","journal-title":"Vaccine"},{"key":"1801_CR3","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(12)60522-4","volume":"379","author":"Simons","year":"2012","unstructured":"Simons E, Ferrari M, Fricks J et al (2012) Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 379:2173\u20132178","journal-title":"Lancet"},{"key":"1801_CR4","unstructured":"World-Health-Organization (2011) Rubella vaccines: WHO position paper. Releve epidemiologique hebdomadaire\/Section d\u2019hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record\/Health Section of the Secretariat of the League of Nations 86:301\u2013316"},{"key":"1801_CR5","unstructured":"World Health Organization (2012) Global measles and rubella strategic plan: 2012\u20132020. World Health Organization, Genf"},{"key":"1801_CR6","first-page":"CD004407","volume":"2","author":"Demicheli","year":"2012","unstructured":"Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C (2012) Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2:CD004407","journal-title":"Cochrane Database Syst Rev"},{"key":"1801_CR7","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/infdis\/jir102","volume":"204","author":"Uzicanin","year":"2011","unstructured":"Uzicanin A, Zimmerman L (2011) Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. J Infect Dis 204(Suppl 1):S133\u2013S148","journal-title":"J Infect Dis"},{"key":"1801_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S0950268802008142","volume":"130","author":"Beutels","year":"2003","unstructured":"Beutels P, Gay NJ (2003) Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country. Epidemiol Infect 130:273\u2013283","journal-title":"Epidemiol Infect"},{"key":"1801_CR9","unstructured":"Just M (1978) Rentiert die Masern- und\/oder Mumps-Impfung f\u00fcr schweizerische VErh\u00e4ltnisse? Schweiz Med Wochenschr 108"},{"key":"1801_CR10","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0264-410X(98)00125-X","volume":"16","author":"Miller","year":"1998","unstructured":"Miller MA, Redd S, Hadler S, Hinman A (1998) A model to estimate the potential economic benefits of measles eradication for the United States. Vaccine 16:1917\u20131922","journal-title":"Vaccine"},{"key":"1801_CR11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0264-410X(97)00281-8","volume":"16","author":"Pelletier","year":"1998","unstructured":"Pelletier L, Chung P, Duclos P et al (1998) A benefit-cost analysis of two-dose measles immunization in Canada. Vaccine 16:989\u2013996","journal-title":"Vaccine"},{"key":"1801_CR12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1472-6963-11-254","volume":"11","author":"Takahashi","year":"2011","unstructured":"Takahashi K, Ohkusa Y, Kim J-Y (2011) The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study. BMC Health Serv Res 11:254","journal-title":"BMC Health Serv Res"},{"key":"1801_CR13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2105\/AJPH.75.7.739","volume":"75","author":"White","year":"1985","unstructured":"White CC, Koplan JP, Orenstein WA (1985) Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health 75:739\u2013744","journal-title":"Am J Public Health"},{"key":"1801_CR14","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1086\/378987","volume":"189","author":"Zhou","year":"2004","unstructured":"Zhou F, Reef S, Massoudi M et al (2004) An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J Infect Dis 189(Suppl 1):S131\u2013S145","journal-title":"J Infect Dis"},{"key":"1801_CR15","first-page":"625","volume":"57","author":"Wiedermann","year":"1979","unstructured":"Wiedermann G, Ambrosch F (1979) Costs and benefits of measles and mumps immunization in Austria. Bull World Health Organ 57:625\u2013629","journal-title":"Bull World Health Organ"},{"key":"1801_CR16","first-page":"115","volume":"46","author":"Bjerregaard","year":"1991","unstructured":"Bjerregaard P (1991) Economic analysis of immunization programmes. Scand J Soc Med Suppl 46:115\u2013119","journal-title":"Scand J Soc Med Suppl"},{"key":"1801_CR17","doi-asserted-by":"crossref","unstructured":"Chapalain MT (1978) Perinatality: French cost-benefit studies and decisions on handicap and prevention. Ciba Found Symp 193\u2013206","DOI":"10.1002\/9780470720417.ch11"},{"key":"1801_CR18","first-page":"419","volume":"43","author":"Elo","year":"1979","unstructured":"Elo O (1979) Cost-benefit studies of vaccinations in Finland. Developments in biological standardization 43:419\u2013428","journal-title":"Developments in biological standardization"},{"key":"1801_CR19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJM197602052940604","volume":"294","author":"Schoenbaum","year":"1976","unstructured":"Schoenbaum SC, Hyde JNJBL, Crampton K (1976) Benefit-cost analysis of rubella vaccination policy. N Engl J Med 294:306\u2013310","journal-title":"N Engl J Med"},{"key":"1801_CR20","first-page":"69","volume":"5","author":"Stray-Pedersen","year":"1982","unstructured":"Stray-Pedersen B (1982) Economic evaluation of different vaccination programmes to prevent congenital rubella. NIPH Ann 5:69\u201383","journal-title":"NIPH Ann"},{"key":"1801_CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/oxfordjournals.aje.a009196","volume":"146","author":"Halloran","year":"1997","unstructured":"Halloran ME, Struchiner CJ, Longini IM Jr (1997) Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 146:789\u2013803","journal-title":"Am J Epidemiol"},{"key":"1801_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/oxfordjournals.epirev.a017931","volume":"18","author":"Chen","year":"1996","unstructured":"Chen RT, Orenstein WA (1996) Epidemiologic methods in immunization programs. Epidemiol Rev 18:99\u2013117","journal-title":"Epidemiol Rev"},{"key":"1801_CR23","first-page":"1055","volume":"63","author":"Orenstein","year":"1985","unstructured":"Orenstein WA, Bernier RH, Dondero TJ et al (1985) Field evaluation of vaccine efficacy. Bull World Health Organ 63:1055\u20131068","journal-title":"Bull World Health Organ"},{"key":"1801_CR24","unstructured":"Kunz R, Ollenschl\u00e4ger G, Raspe HH et al (2007) Lehrbuch f\u00fcr Evidenzbasierte Medizin in Klinik und Praxis. Deutscher \u00c4rzte-Verlag, K\u00f6ln"},{"key":"1801_CR25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ije\/22.4.742","volume":"22","author":"Farrington","year":"1993","unstructured":"Farrington CP (1993) Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 22:742\u2013746","journal-title":"Int J Epidemiol"},{"key":"1801_CR26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/652404","volume":"201","author":"Weinberg","year":"2010","unstructured":"Weinberg GA, Szilagyi PG (2010) Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis 201:1607\u20131610","journal-title":"J Infect Dis"},{"key":"1801_CR27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bmb\/62.1.201","volume":"62","author":"Salisbury","year":"2002","unstructured":"Salisbury DM, Beverley PCL, Miller E (2002) Vaccine programmes and policies. Br Med Bull 62:201\u2013211","journal-title":"Br Med Bull"},{"key":"1801_CR28","unstructured":"Briggs A, Claxton K, Sculpher M (2008) Decision modelling for health economic evaluation. Oxford University Press, Oxford"},{"key":"1801_CR29","doi-asserted-by":"crossref","unstructured":"Siebert U, M\u00fchlberger N, Sch\u00f6ffski O (2008) Evidenzsynthese: meta-Analysen und Entscheidungsanalysen. In: Sch\u00f6ffski O, von der Schulenburg JM (Hrsg) Gesundheits\u00f6konomische Evaluation. Springer, Berlin Heidelberg New York Tokyo, S\u00a0261\u2013310","DOI":"10.1007\/978-3-540-49559-8_11"},{"key":"1801_CR30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/14760584.2.5.649","volume":"2","author":"Beutels","year":"2003","unstructured":"Beutels P, Van Doorslaer E, Van Damme P, Hall J (2003) Methodological issues and new developments in the economic evaluation of vaccines. Expert Rev Vaccines 2:649\u2013660","journal-title":"Expert Rev Vaccines"},{"key":"1801_CR31","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1098\/rsif.2011.0062","volume":"8","author":"Pitzer","year":"2011","unstructured":"Pitzer VE, Viboud C, Lopman BA et al (2011) Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence. J R Soc Interface 8:1584\u20131593","journal-title":"J R Soc Interface"},{"key":"1801_CR32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2009-1653","volume":"125","author":"Sugerman","year":"2010","unstructured":"Sugerman DE, Barskey AE, Delea MG et al (2010) Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 125:747\u2013755","journal-title":"Pediatrics"},{"key":"1801_CR33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a010145","volume":"151","author":"De","year":"2000","unstructured":"De Serres G, Gay NJ, Farrington CP (2000) Epidemiology of transmissible diseases after elimination. Am J Epidemiol 151:1039\u20131048 (discussion 1049\u20131052)","journal-title":"Am J Epidemiol"},{"key":"1801_CR34","doi-asserted-by":"crossref","unstructured":"Icks A, Chernyak N, Bestehorn K et al (2010) Methoden der gesundheits\u00f6konomischen Evaluation in der Versorgungsforschung. Gesundheitswesen","DOI":"10.1055\/s-0030-1262859"},{"key":"1801_CR35","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1093\/infdis\/jir114","volume":"204","author":"Garrison","year":"2011","unstructured":"Garrison LP, Bauch CT, Bresnahan BW et al (2011) Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination. J Infect Dis 204:S124\u2013S132","journal-title":"J Infect Dis"},{"key":"1801_CR36","unstructured":"IQWiG (2009) Cost estimation \u2013 working paper, Version 1.0. Gesundheitswesen IfQuWi (Hrsg) Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen Cologne"},{"key":"1801_CR37","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.vaccine.2007.04.070","volume":"25","author":"Drummond","year":"2007","unstructured":"Drummond M, Chevat C, Lothgren M (2007) Do we fully understand the economic value of vaccines? Vaccine 25:5945\u20135957","journal-title":"Vaccine"},{"key":"1801_CR38","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ffski O (2008) Grundformen gesundheits\u00f6konomischer Evaluationen. In: Sch\u00f6ffski O, von der Schulenburg JM (Hrsg) Gesundheits\u00f6konomische Evaluation. Springer, Berlin Heidelberg New York Tokyo, S\u00a065\u201392","DOI":"10.1007\/978-3-540-49559-8_5"},{"key":"1801_CR39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5694\/j.1326-5377.2008.tb01500.x","volume":"188","author":"Raftery","year":"2008","unstructured":"Raftery JP (2008) Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand. Med J Aust 188:26\u201328","journal-title":"Med J Aust"},{"key":"1801_CR40","unstructured":"NICE (2008) National Institute for Health and Clinical Excellence: guide to the methods of technology appraisal. In: System NH (Hrsg)"},{"key":"1801_CR41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.inf.0000172900.70430.c2","volume":"24","author":"Arenz","year":"2005","unstructured":"Arenz S, Schmitt HJ, Tischer A, Kries R von (2005) Effectiveness of measles vaccination after household exposure during a measles outbreak: a household contact study in Coburg, Bavaria. Pediatr Infect Dis J 24:697\u2013699","journal-title":"Pediatr Infect Dis J"},{"key":"1801_CR42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/INF.0b013e318060aca1","volume":"26","author":"Wichmann","year":"2007","unstructured":"Wichmann O, Hellenbrand W, Sagebiel D et al (2007) Large measles outbreak at a German public school, 2006. Pediatr Infect Dis J 26:782\u2013786","journal-title":"Pediatr Infect Dis J"},{"key":"1801_CR43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archpedi.1969.02100040303027","volume":"118","author":"Beasley","year":"1969","unstructured":"Beasley RP, Detels R, Kim KS et al (1969) Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27\u20133 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines. Am J Dis Child 118:301\u2013306","journal-title":"Am J Dis Child"},{"key":"1801_CR44","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1586\/erv.10.99","volume":"9","author":"Davidkin","year":"2010","unstructured":"Davidkin I, Kontio M, Paunio M, Peltola H (2010) MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines 9:1045\u20131053","journal-title":"Expert Rev Vaccines"},{"key":"1801_CR45","unstructured":"P\u00f6hn HP, Rasch G (1994) Statistik meldepflichtiger \u00fcbertragbarer Krankheiten: Vom Beginn der Aufzeichnungen bis heute (Stand 31. Dezember 1989). MMV Medizin, M\u00fcnchen"},{"key":"1801_CR46","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00103-012-1539-7","volume":"55","author":"Klein","year":"2012","unstructured":"Klein S, Schoneberg I, Krause G (2012) The historical development of immunization in Germany. From compulsory smallpox vaccination to a National Action Plan on Immunization. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 55:1512\u20131523","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1801_CR47","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.1093\/infdis\/jir068","volume":"204","author":"Siedler","year":"2011","unstructured":"Siedler A, Mankertz A, Feil F et al (2011) Closer to the goal: efforts in measles elimination in Germany 2010. J Infect Dis 204(Suppl 1):S373\u2013S380","journal-title":"J Infect Dis"},{"key":"1801_CR48","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3201\/eid1809.111578","volume":"18","author":"Bonacic","year":"2012","unstructured":"Bonacic Marinovic AA, Swaan C, Wichmann O et al (2012) Effectiveness and timing of vaccination during school measles outbreak. Emerg Infect Dis 18:1405\u20131413","journal-title":"Emerg Infect Dis"},{"key":"1801_CR49","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1016\/S0264-410X(03)00534-6","volume":"21","author":"Carabin","year":"2003","unstructured":"Carabin H, Edmunds WJ, Gyldmark M et al (2003) The cost of measles in industrialised countries. Vaccine 21:4167\u20134177","journal-title":"Vaccine"},{"key":"1801_CR50","unstructured":"Rosian-Schikuta I, Fr\u00f6schl B, Habl C, St\u00fcrzliner H (2007) Die Masern-Mumps-R\u00f6teln-Impfung aus gesundheitspolitischer und \u00f6konomischer Sicht (2007). In: (DIMDI) DIfMDuI (Hrsg) Health technology assessment, Bd\u00a062"},{"key":"1801_CR51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2165\/00019053-200422130-00004","volume":"22","author":"Welte","year":"2004","unstructured":"Welte R, Feenstra T, Jager H, Leidl R (2004) A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics 22:857\u2013876","journal-title":"Pharmacoeconomics"},{"key":"1801_CR52","first-page":"466","volume":"24","author":"Marolla","year":"1998","unstructured":"Marolla F, Baviera G, Cacciapuoti et al (1998) A field study on vaccine efficacy against mumps of three MMR vaccines [Efficacia verso la parotite di tre diversi vaccini a tripla componente: studio sul campo]. Riv Ital Pediatr 24:466\u2013472","journal-title":"Riv Ital Pediatr"},{"key":"1801_CR53","first-page":"656","volume":"48","author":"Ong","year":"2007","unstructured":"Ong G, Rasidah N, Wan S, Cutter J (2007) Outbreak of measles in primary school students with high first dose MMR vaccination coverage. Singapore Med J 48:656\u2013661","journal-title":"Singapore Med J"},{"key":"1801_CR54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/498902","volume":"42","author":"Marin","year":"2006","unstructured":"Marin M, Nguyen HQ, Langidrik JR et al (2006) Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis 42:315\u2013319","journal-title":"Clin Infect Dis"},{"key":"1801_CR55","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.1969.03150190029005","volume":"207","author":"Grayston","year":"1969","unstructured":"Grayston JT, Detels R, Chen KP et al (1969) Field trial of live attenuated rubella virus vaccine during an epidemic on Taiwan. Preliminary report of efficacy of three HPV-77 strain vaccines in the prevention of clinical rubella. JAMA 207:1107\u20131110","journal-title":"JAMA"},{"key":"1801_CR56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM197007302830507","volume":"283","author":"Chang","year":"1970","unstructured":"Chang TW, Des Rosiers S, Weinstein L (1970) Clinical and serologic studies of an outbreak of rubella in a vaccinated population. N Engl J Med 283:246\u2013248","journal-title":"N Engl J Med"},{"key":"1801_CR57","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jama.1970.03170320015002","volume":"213","author":"Furukawa","year":"1970","unstructured":"Furukawa T, Miyata T, Kondo K et al (1970) Rubella vaccination during an epidemic. JAMA 213:987\u2013990","journal-title":"JAMA"},{"key":"1801_CR58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jama.1971.03180170036007","volume":"215","author":"Davis","year":"1971","unstructured":"Davis WJ, Larson HE, Simsarian JP et al (1971) A study of rubella immunity and resistance to infection. JAMA 215:600\u2013608","journal-title":"JAMA"},{"key":"1801_CR59","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jama.1974.03230240041022","volume":"227","author":"Landrigan","year":"1974","unstructured":"Landrigan PJ, Stoffels MA, Anderson E, Witte JJ (1974) Epidemic rubella in adolescent boys. Clinical features and results of vaccination. JAMA 227:1283\u20131287","journal-title":"JAMA"},{"key":"1801_CR60","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00006454-198307000-00005","volume":"2","author":"Greaves","year":"1983","unstructured":"Greaves WL, Orenstein WA, Hinman AR, Nersesian WS (1983) Clinical efficacy of rubella vaccine. Pediatr Infect Dis 2:284\u2013286","journal-title":"Pediatr Infect Dis"},{"key":"1801_CR61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0264-410X(85)90058-1","volume":"3","author":"Strassburg","year":"1985","unstructured":"Strassburg MA, Greenland S, Stephenson TG et al (1985) Clinical effectiveness of rubella vaccine in a college population. Vaccine 3:109\u2013112","journal-title":"Vaccine"},{"key":"1801_CR62","unstructured":"Valk H de, Rebi\u00e8re I (1998) Epid\u00e9mie de rub\u00e9ole: Evaluation de l\u2019effi cacit\u00e9 vaccinale sur le terrain, Ard\u00e8che, janvier mars 1997. R\u00e9seau National de sant\u00e9 Publique, Saint Maurice, France, 1\u201352"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-013-1801-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1801-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T19:56:02Z","timestamp":1596398162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-013-1801-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,31]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1007\/s00103-013-1801-7","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,31]]}}}